home / stock / mreo / mreo news

MREO News and Press, Mereo BioPharma Group From 06/04/20

Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...
MREO - Mereo Bio completes $70M private placement; advances etigilimab into Phase 1b study

Mereo BioPharma ( MREO +56.9% ) has completed $70M (£56M) private placement (the “Fundraising”). More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move, Read more ...

MREO - AAL, NIO among premarket gainers

Cinedigm (NASDAQ: CIDM ) +139%  on partnering with Vewd for global OTT channel distribution. More news on: Cinedigm Corp., Kezar Life Sciences, Inc., LiveXLive Media, Inc., Stocks on the move, , Read more ...

MREO - Mereo BioPharma Announces Completion of $70 Million Private Placement

LONDON and REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) today announces the completion of a $70 million (£56 million) private placement (the “Fundraising”) with a number of new and existing U.S based institutio...

MREO - RGA, ARCE among premarket losers

Evofem Biosciences (NASDAQ: EVFM )  -26%  after pricing equity offering. More news on: Evofem Biosciences, Inc., Cellectar Biosciences, Inc., Reinsurance Group of America, Incorporated, Stocks on the move, , Read more ...

MREO - Mereo Bio updates business amid COVID-19

Mereo BioPharma Group (NASDAQ: MREO ) provides an update on  business and developmental programs, in response to COVID-19 pandemic. More news on: Mereo BioPharma Group plc, Healthcare stocks news, Read more ...

MREO - Business Update and Directorate Change

LONDON and REDWOOD CITY, Calif., March 27, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on rare diseases, today provided a general business update, includi...

MREO - Mereo BioPharma Announces Positive Feedback from Type B End-of-Phase 2 Meeting with the FDA and Outlines Pivotal Phase 3 Pediatric Study Design for Setrusumab in Osteogenesis Imperfecta

LONDON and REDWOOD CITY, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or the "Company," a clinical stage biopharmaceutical company focused on rare diseases, today announced the successful completion of a Type B End-of-Phase 2 meeting ...
MREO - Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor

LONDON and REDWOOD CITY, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or the "Company," today announced that it has entered into a Securities Purchase Agreement (the “Agreement”) with a new U.S.-based institutional healt...

MREO - Mereo BioPharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab

LONDON and REDWOOD CITY, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or the "Company," today announced that it is distributing approximately 1.2 cents cash per Contingent Value Right (“CVR”), a total of approximately $4...

MREO - TCO, NNVC, GPOR and JE among midday movers

Gainers: vTv Therapeutics (NASDAQ: VTVT )  +57% . More news on: vTv Therapeutics Inc., Taubman Centers, Inc., NanoViricides, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10